Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

roche registration gmbh - baloxavir marboxil - influensa, human - antivirale midler til systemisk bruk - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - andre nervesystemet narkotika - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

bayer ag - vericiguat - hjertefeil - hjertetapi - treatment of symptomatic chronic heart failure.

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

diurnal europe b.v. - hydrokortison - adrenal hyperplasia, congenital - kortikosteroider for systemisk bruk - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - preparater for behandling av sår og sår - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

biomarin international limited - valoctocogene roxaparvovec - antihemoragika - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

csl behring gmbh - etranacogene dezaparvovec - hemofili b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - deucravacitinib - psoriasis - immunsuppressive - treatment of moderate-to-severe plaque psoriasis in adults.

Liên Minh Châu Âu - Tiếng Na Uy - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplasmer, kastrering-resistant - antineoplastiske midler - treatment of adult patients with prostate cancer.